Stockscreener 앱 받기
0.00
100.00%
-47.98
전일 마감가:
$47.98
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$1.23B
수익:
-
순이익/손실:
$11.77M
주가수익비율:
0.00
EPS:
0.5785
순현금흐름:
$-19.23M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$48.27
Tourmaline Bio Inc Stock (TRML) Company Profile
명칭
Tourmaline Bio Inc
전화
646-481-9832
주소
27 WEST 24TH STREET, NEW YORK
Compare TRML vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
0.00 | 1.23B | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | BMO Capital Markets | Outperform |
| 2024-11-11 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-15 | 개시 | Jefferies | Buy |
| 2023-12-04 | 재개 | H.C. Wainwright | Buy |
| 2023-11-17 | 개시 | Truist | Buy |
| 2023-10-31 | 개시 | Guggenheim | Buy |
| 2023-10-25 | 개시 | Piper Sandler | Overweight |
| 2022-10-20 | 개시 | H.C. Wainwright | Buy |
| 2022-07-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
모두보기
Tourmaline Bio Inc 주식(TRML)의 최신 뉴스
Is Tourmaline Bio Inc. stock a good pick for beginnersQuarterly Performance Summary & Technical Confirmation Trade Alerts - mfd.ru
What is Tourmaline Bio Inc. s debt to equity ratioJuly 2025 Recap & Reliable Breakout Stock Forecasts - mfd.ru
What’s Tourmaline Bio Inc.’s historical returnTrade Exit Report & Stock Portfolio Risk Control - mfd.ru
Can Tourmaline Bio Inc. stock continue upward trendJuly 2025 Intraday Action & Community Shared Stock Ideas - mfd.ru
Gains Recap: Is Tourmaline Bio Inc a speculative investmentJuly 2025 Price Swings & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Growth Report: Is Tourmaline Bio Inc a speculative investmentProduct Launch & AI Powered Market Entry Strategies - baoquankhu1.vn
Aug Retail: How do insiders feel about The TJX Companies IncProfit Target & Capital Protection Trading Alerts - baoquankhu1.vn
Published on: 2026-02-05 17:38:59 - baoquankhu1.vn
Levels Update: Is Tourmaline Bio Inc. stock undervalued right nowWeekly Gains Report & Trade Opportunity Analysis Reports - mfd.ru
Market Wrap: What is the next catalyst for Tourmaline Bio IncJuly 2025 Catalysts & Low Drawdown Momentum Ideas - baoquankhu1.vn
What are Tourmaline Bio Inc.’s recent SEC filings showingMarket Weekly Review & Technical Buy Zone Confirmation - mfd.ru
Growth Review: What is the dividend yield of Tourmaline Bio IncTrade Exit Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Valuation Update: What is ZIMVs TAM Total Addressable MarketPortfolio Performance Report & Intraday High Probability Alerts - baoquankhu1.vn
H.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 Results - MSN
HOKA Fit Guide: Why Tourmaline Bio Inc. stock could see breakout soonCushioning Options Review & what to check before ordering - ulpravda.ru
Is Tourmaline Bio Inc. stock overvalued by current metricsWeekly Trading Summary & Intraday High Probability Alerts - ulpravda.ru
Why Tourmaline Bio Inc. stock could see breakout soonEarnings Growth Summary & Daily Chart Pattern Signal Reports - Улправда
Will Tourmaline Bio Inc. stock continue dividend increasesJuly 2025 Patterns & Low Drawdown Trading Strategies - Улправда
Portfolio Shifts: Why Tourmaline Bio Inc stock could see breakout soonJuly 2025 Short Interest & Safe Capital Growth Tips - moha.gov.vn
Can Tourmaline Bio Inc. stock outperform in 2025 bull marketBond Market & Community Consensus Stock Picks - Улправда
Is Tourmaline Bio Inc. stock oversold or undervaluedJuly 2025 Highlights & Weekly Stock Breakout Alerts - Улправда
How Tourmaline Bio Inc. stock performs after earnings2025 Market Sentiment & AI Driven Price Predictions - Улправда
Gains Recap: How Tourmaline Bio Inc. stock performs after earnings2025 Market Sentiment & Stepwise Trade Signal Guides - ulpravda.ru
Movement Recap: What catalysts could drive Tourmaline Bio Inc stock higherRate Cut & Precise Buy Zone Tips - BỘ NỘI VỤ
Will Tourmaline Bio Inc. stock outperform value stocksQuarterly Portfolio Review & Safe Swing Trade Setups - newser.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Is Tourmaline Bio Inc. stock attractive after correctionTrade Entry Summary & Verified Short-Term Plans - newser.com
How to manage a losing position in Tourmaline Bio Inc.Market Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Will Tourmaline Bio Inc. stock reach all time highs in 2025Trade Performance Summary & Safe Swing Trade Setups - newser.com
Combining machine learning predictions for Tourmaline Bio Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
How Tourmaline Bio Inc. stock performs in rate cut cyclesJuly 2025 PostEarnings & Verified Chart Pattern Signals - newser.com
Is Tourmaline Bio Inc. stock a top pick in earnings seasonAnalyst Downgrade & Smart Allocation Stock Tips - newser.com
[EFFECT] Tourmaline Bio, Inc. SEC Filing - Stock Titan
Using Bollinger Bands to evaluate Tourmaline Bio Inc.Portfolio Gains Report & Daily Technical Forecast Reports - newser.com
Tourmaline Bio Inc. recovery potential after sell offPortfolio Performance Report & Consistent Profit Focused Trading Strategies - newser.com
How institutional buying supports Tourmaline Bio Inc. stockJuly 2025 Momentum & Low Risk High Win Rate Stock Picks - Fundação Cultural do Pará
How to monitor Tourmaline Bio Inc. with trend dashboardsQuarterly Profit Review & Step-by-Step Swing Trade Plans - newser.com
Tourmaline Bio Inc (TRML) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):